The approval was based on a bioavailability study comparing the efficacy of Zonisade oral suspension to zonisamide capsules in healthy individuals. The Food and Drug Administration (FDA) has approved ...
New label marks the first Bruton’s tyrosine kinase inhibitor to be approved with an oral suspension formulation. The FDA has approved an addendum to the Imbruvica (ibrutinib) label to include an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback